42913 Assessment of Therapeutic Equivalence Between Candidate Biosimilar AVT04 and Reference Ustekinumab
Stroissnig, Heimo, Feldman, Steven, Berti, Fausto, Duijzings, Paul, Ruffieux, Ruth, Sobierska, Joanna, Otto, Hendrik, Haliduola, Halimu
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
42601 Assessment of Bioequivalence Between Candidate Biosimilar AVT04 and Reference Ustekinumab
Berti, Fausto, Wynne, Chris, Stroissnig, Heimo, Smith, Matthew, Duijzings, Paul, Ruffieux, Ruth, Sobierska, Joanna, Otto, Hendrik, Sattar, Abid, Haliduola, Halimu
Published in Journal of the American Academy of Dermatology (01.09.2023)
Published in Journal of the American Academy of Dermatology (01.09.2023)
Get full text
Journal Article
A randomized, double-blind, 3-arm, parallel study assessing the pharmacokinetics, safety, tolerability and immunogenicity of AVT04, an ustekinumab candidate biosimilar, in healthy adults
Wynne, Christopher, Hamilton, Paul, McLendon, Kristi, Stroissnig, Heimo, Smith, Matthew, Duijzings, Paul, Ruffieux, Ruth, Otto, Hendrik, Sattar, Abid, Haliduola, Halimu N., Leutz, Steffen, Berti, Fausto
Published in Expert opinion on investigational drugs (04.05.2023)
Published in Expert opinion on investigational drugs (04.05.2023)
Get full text
Journal Article
Randomized, double-blind, multicenter study to evaluate efficacy, safety, tolerability, and immunogenicity between AVT04 and the reference product ustekinumab in patients with moderate-to-severe chronic plaque psoriasis
Feldman, Steven R, Reznichenko, Nataliya, Berti, Fausto, Duijzings, Paul, Ruffieux, Ruth, Otto, Hendrik, Haliduola, Halimu N, Leutz, Steffen, Stroissnig, Heimo
Published in Expert opinion on biological therapy (03.08.2023)
Published in Expert opinion on biological therapy (03.08.2023)
Get full text
Journal Article
Assessing the Interchangeability of AVT02 and Humira® in Participants with Moderate‑to‑Severe Chronic Plaque Psoriasis: Pharmacokinetics, Efficacy, Safety, and Immunogenicity Results from a Multicenter, Double-Blind, Randomized, Parallel-Group Study
Feldman, Steven R., Kay, Richard, Reznichenko, Nataliya, Sobierska, Joanna, Dias, Roshan, Otto, Hendrik, Haliduola, Halimu N., Sattar, Abid, Ruffieux, Ruth, Stroissnig, Heimo, Berti, Fausto
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.07.2023)
Published in BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy (01.07.2023)
Get full text
Journal Article
Design and synthesis of novel nonpolar host peptides for the determination of the 310- and α-helix compatibilities of α-amino acid buildig blocks: An assessment of α,α-disubstituted glycines
Obrecht, Daniel, Altorfer, Michael, Bohdal, Udo, Daly, John, Huber, Walter, Labhardt, Alexander, Lehmann, Christian, Müller, Klaus, Ruffieux, Ruth, Schönholzer, Peter, Spiegler, Clive, Zumbrunn, Cornelia
Published in Biopolymers (15.10.1997)
Published in Biopolymers (15.10.1997)
Get full text
Journal Article